IFN-γ in uncomplicated and severe malaria in children

Nisreen Daffa Alla, M. Y. Sukkar


Background: Immunity against malaria appears to require early production of IFN-γ, which may
occur following repeated infections. However, its excessive uncontrolled production leads to malaria
complications. Some studies report the protective role of IFN-γ against severe anaemia while other reports
link its production with cerebral malaria.
Objectives: the aim of this study was to measure and compare serum IFN-γ levels between children
presenting with uncomplicated and those with severe malaria (SM). We also investigated the variation in
IFN-γ response with age.
Materials and methods: The study is a cross-sectional study conducted at Wad Medani Paediatric
Hospital in the period September 2007 to September 2008. Fifty-six children with SM, identified according
to WHO criteria, were included in the study. Thirty-one children with uncomplicated malaria (UM) were
included for comparison. The following parameters were measured: parasitemia, Hb, RBG, TWBC, liver
enzymes, bilirubin, urea, creatinine, sodium, potassium and the cytokine IFN-γ.
Results: The mean age of children with UM was 82.71 months while in SM it was 56.75 (p value 0.001).
Children older than 5 years showed significantly higher IFN-γ level than those 5 years or below. Children
with cerebral malaria showed higher levels than those with UM and then those with other severe malaria
manifestations but this were not statically significant. Significant positive correlation was detected between
IFN-γ and haemoglobin and the lowest mean IFN-γ level was found in those with severe anaemia.
Conclusions: Old age, UM and CM were associated with high IFN-γ levels. The high IFN-γ level associated
with higher haemoglobin concentration seems to protect against the development of severe anaemia.


IFN-γ;uncomplicated;severe ;malaria; children

Full Text:



World malaria report 2013. http://www.who.



Abdalla SI, Malik EM, Ali KM. The burden

of malaria in Sudan: incidence, mortality and

disability – adjusted life – years. Malaria

Journal 2007; 6:97

Gupta S, Snow RW, Donnelly CHA, Marsh K,

Newbold CH. Immunity to non-cerebral severe

malaria is acquired after one or two infections.

Nature Medicine 1999; 5: 340 - 343

Ombrain M, Robinson LJ, Stanisic DI et al.

Association of early interferon-γ production

with immunity to clinical malaria: a Longitudinal

study among Papua New Guinean Children.

Clinical Infectious Diseases 2008; 47: 1380-1387.

Miller JL, Sack BK, Baldwin M, Vaughan AM,

Kappe SH. Interferon mediated innate immune

responses against malaria parasite liver stages.

Cell Rep 2014; 24: 436-47

Luty AJ, Lell B, Schmidt-Ott R. Interferongamma

responses are associated with resistance

to reinfection with Plasmodium falciparum

in young African children. J Infect Dis 1999;


Moormann AM, Sumba PO, Chelimo K et al.

Humoral and cellular immunity to Plasmodium

falciparum merozoite surface protein 1 and

protection from infection with blood-stage

parasites. J Infect Dis 2013; 208: 149–158

Tsakonas KA, Riley AM. Innate immune

response to malaria: Rapid induction of IFN-γ

from human NK cells by live Plasmodium

falciparum infected erythrocytes. J Immunol

; 169: 2956-2963

Walther M, Woodruff J, Edele FD et al.

Innate immune responses to human malaria:

Heterogeneous cytokine responses to bloodstage

Plasmodium falciparum correlate with

parasitological and clinical outcomes. J Immunol

; 177:5736-5745

John CHC, Moormann AM, Sumba PO,

Ofulla AV, Pregibon DC, Kazura LW. Gamma

interferon responses to plasmodium falciparum

liver stage antigen 1 and thrombospondinrelated

adhesive protein and their relationship

to age, transmission intensity, and protection

against malaria. Infect Immun 2004; 72: 5135–

Krupka M, Seydel K, Feintuch CM et al. Mild

Plasmodium falciparum malaria following an

episode of severe malaria is associated with

induction of the interferon pathway in Malawian

children. Infect Immun 2012; 80: 1150-1155

Grau GE, Heremans H, Piguet PF et al.

Monoclonal antibody against interferon gamma

can prevent experimental cerebral malaria and

its associated over production of tumor necrosis.

PNAS 1989; 86: 5572-5574

Rudin W, Favre N, Bordmann G, Ryffel B.

Interferon- is essential for the development

of cerebral malaria. Eur J Immunol 2005; 27: 810

– 815

Weiser S, Miu J, Ball HJ, Hunt NH. Cytokine:

Interferon-gamma synergizes with tumor

necrosis factor and lymphotoxin-alpha to

enhance the mRNA and protein expression of

adhesion molecules in mouse brain endothelial

cells. Cytokines 2007; 37:84-91

Claser C, Malleret B, Yee Gun S et al. CD8+

T Cells and IFN-γ mediate the time-dependent

accumulation of infected red blood cells in deep

organs during experimental cerebral malaria.

PLos One 2011; 6: e18720

Belnoue E, Potter SM, Rosa DS et al. Control of

pathogenic CD8+ T cell migration to the brain

by IFN-gamma during experimental cerebral

malaria. Parasite Immunol. 2008; 30:544-53

Sanni LA, Thomas SR, Tattam BN. Dramatic

changes in oxidative t r y p t o p h a n

metabolism along the kynurenine pathway in

experimental cerebral and non-cerebral malaria.

Am J Pathol 1998; 152:611–9

Nisreen Daffa Alla, M.Y. Sukkar

Liehl P, Zuzarte- Luís V, Chan J et al. Hostcell

sensors for Plasmodium activate innate

immunity against liver-stage infection. Nat

Med 2014;20:47–53

Winkler S, Willheim M, Baier K. Frequency

of cytokine-producing T cells in patients

of different age groups with Plasmodium

falciparum malaria. J Infect Dis 1999; 179:209


  • There are currently no refbacks.

ISSN: 1858-5345